| Message: | Hgh Fragment 176-191
Description:
Hgh Fragment 176-191 is a fat-loss peptide derived from the GH molecule, which directly initiates lipolysis and inhibits lipogenesis, but in order to better understand this peptide, it is imperative to have at least a rudimentary understanding of its parent hormone, GH. Growth hormone is a polypeptide which contains an amino acid sequence that is 191 amino acids in length. Frag (176-191) was developed by isolating and modifying the specific portion of the GH molecule responsible for the hormone’s lipolytic and anti-lipogenic effects. The portion of the molecule responsible for these effects is amino acids #176-191. In every sense, Frag should primarily be considered a fat loss peptide which performs these functions through the same pathways as traditional GH, but without exposing the user to the potentially undesirable side effects which may present themselves during GH administration.
Unlike GH, Frag (176-191) has no effect on insulin sensitivity and therefore, will not contribute to insulin resistance. This is a noteworthy benefit, particularly for those individuals who exhibit impaired insulin sensitivity, yet still wish to experience the fat loss benefits that GH has to offer without further contributing to insulin resistance. IGF-1 levels also remain unaffected by Frag.
Common benefits of Frag (176-191) include:
* An increased rate of lipolysis.
* Inhibition of lipogenesis |
my account
